---
figid: PMC7520283__JCMM-24-9518-g004
figtitle: Wnt/B‐catenin signalling pathway in OA‐FLS inflammation
organisms:
- NA
pmcid: PMC7520283
filename: JCMM-24-9518-g004.jpg
figlink: pmc/articles/PMC7520283/figure/jcmm15669-fig-0004/
number: F4
caption: 'Wnt/β‐catenin signalling pathway in OA‐FLS inflammation. FoxC1, a target
  gene of miR‐200a‐3p, promoted human OA‐FLS proliferation, pro‐inflammatory cytokine
  and catabolic enzymes expression by elevated β‐catenin production. IL‐1β inhibited
  miR‐200a‐3p enhanced the effects of FoxC1 in human OA‐FLS. XAV‐939, a small‐molecule
  inhibitor of Wnt pathway, reduced proliferation and I collagen levels of OA‐FLS.
  Lorecivivint, a small‐molecule Wnt pathway inhibitor, declined pro‐inflammatory
  cytokines by inhibiting NF‐κB and STAT3 phosphorylation through reduced CLK2 and
  DYRK1A production in human OA‐FLS. LRP5/6: Lipoprotein receptor‐associated protein;
  GSK3β: Glycogen synthase kinase 3β; CK1: Casein kinase 1; APC: Adenomatous polyposis
  coli; LEF/TCF: Lymphoid enhancer factor/T‐cell; CLK2: CDC‐like kinase 2; DYRK1A:
  Dual‐specificity tyrosine phosphorylation‐regulated kinase 1A'
papertitle: 'The emerging role of fibroblast‐like synoviocytes‐mediated synovitis
  in osteoarthritis: An update.'
reftext: Dafei Han, et al. J Cell Mol Med. 2020 Sep;24(17):9518-9532.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9494586
figid_alias: PMC7520283__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7520283__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7520283__JCMM-24-9518-g004.html
  '@type': Dataset
  description: 'Wnt/β‐catenin signalling pathway in OA‐FLS inflammation. FoxC1, a
    target gene of miR‐200a‐3p, promoted human OA‐FLS proliferation, pro‐inflammatory
    cytokine and catabolic enzymes expression by elevated β‐catenin production. IL‐1β
    inhibited miR‐200a‐3p enhanced the effects of FoxC1 in human OA‐FLS. XAV‐939,
    a small‐molecule inhibitor of Wnt pathway, reduced proliferation and I collagen
    levels of OA‐FLS. Lorecivivint, a small‐molecule Wnt pathway inhibitor, declined
    pro‐inflammatory cytokines by inhibiting NF‐κB and STAT3 phosphorylation through
    reduced CLK2 and DYRK1A production in human OA‐FLS. LRP5/6: Lipoprotein receptor‐associated
    protein; GSK3β: Glycogen synthase kinase 3β; CK1: Casein kinase 1; APC: Adenomatous
    polyposis coli; LEF/TCF: Lymphoid enhancer factor/T‐cell; CLK2: CDC‐like kinase
    2; DYRK1A: Dual‐specificity tyrosine phosphorylation‐regulated kinase 1A'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AXIN1
  - AXIN2
  - CLK2
  - TELO2
  - GSK3B
  - CSNK1A1
  - FOXC1
  - APC
  - PROC
  - CTNNB1
  - NFKB1
  - STAT3
  - HNF4A
---
